1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Diabetes and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: a pre-specified analysis from the randomised TROPICAL-ACS trial.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A guided de-escalation of P2Y12 inhibitor treatment is considered an alternative treatment strategy in ACS patients undergoing PCI. However, the safety and efficacy of this strategy may differ in diabetic vs non-diabetic patients. The aim of this study was to compare the outcomes of platelet function testing (PFT)-guided de-escalation of dual antiplatelet therapy (DAPT) in ACS patients with and without diabetes mellitus.

          Related collections

          Author and article information

          Journal
          EuroIntervention
          EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
          Europa Digital & Publishing
          1969-6213
          1774-024X
          August 09 2019
          : 15
          : 6
          Affiliations
          [1 ] Ludwig-Maximilians University, Department of Cardiology, Munich, Germany.
          Article
          EIJ-D-18-01077
          10.4244/EIJ-D-18-01077
          31012853
          574b6119-39d9-4602-b87d-8b120bc40e0f

          Comments

          Comment on this article